Edition:
United States

People: ZMH Hammerman Ltd (ZMH.TA)

ZMH.TA on Tel Aviv Stock Exchange

1,196.00ILa
25 Jun 2017
Change (% chg)

0.00 (+0.00%)
Prev Close
1,196.00
Open
1,196.00
Day's High
1,196.00
Day's Low
1,196.00
Volume
12
Avg. Vol
10,572
52-wk High
1,512.00
52-wk Low
1,146.00

Pickett, Cecil 

Dr. Cecil B. Pickett, Ph.D., is Independent Director of Zimmer Biomet Holdings, Inc. He is the President, Research and Development and a member of the board of directors of Biogen Idec Inc. from September 2006 until his retirement in October 2009. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, including Corporate Senior Vice President of Schering-Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co. Dr. Pickett received a B.S. in biology from California State University at Hayward and a Ph.D. in cell biology from University of California at Los Angeles.

Basic Compensation

Total Annual Compensation, USD 107,000
Restricted Stock Awards, USD 187,620
Long-Term Incentive Plans, USD --
All Other, USD 6,582
Fiscal Year Total, USD 301,202

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --